Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Hatanaka, Kunihiko ^a,b   Lanahan, Anthony A ^a   Murakami, Masahiro ^a   Simons, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATENIN; FIBROBLAST GROWTH FACTOR; PROTEIN TYROSINE PHOSPHATASE SHP 2; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL JUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ADHERENS JUNCTIONS; ANIMALS; ANTIGENS, CD; CADHERINS; CAPILLARY PERMEABILITY; CATTLE; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; SIGNAL TRANSDUCTION;

EID: 84861302593     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037600     Document Type: Article

References (43)

1. Dejana E, Tournier-Lasserve E, Weinstein BM, (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 16: 209-221.
2. Vestweber D, Broermann A, Schulte D, (2010) Control of endothelial barrier function by regulating vascular endothelial-cadherin. Curr Opin Hematol 17: 230-236.
3. Harris ES, Nelson WJ, (2010) VE-cadherin: at the front, center, and sides of endothelial cell organization and function. Curr Opin Cell Biol 22: 651-658.
4. Murakami M, Simons M, (2009) Regulation of vascular integrity. J Mol Med 87: 571-582.
5. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, et al. (2008) Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10: 923-934.
6. Vestweber D, Winderlich M, Cagna G, Nottebaum AF, (2009) Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol 19: 8-15.
7. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, et al. (1999) Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98: 147-157.
8. Xiao K, Garner J, Buckley KM, Vincent PA, Chiasson CM, et al. (2005) p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin. Mol Biol Cell 16: 5141-5151.
9. Andriopoulou P, Navarro P, Zanetti A, Lampugnani MG, Dejana E, (1999) Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler Thromb Vasc Biol 19: 2286-2297.
10. Shasby DM, Ries DR, Shasby SS, Winter MC, (2002) Histamine stimulates phosphorylation of adherens junction proteins and alters their link to vimentin. Am J Physiol Lung Cell Mol Physiol 282: L1330-1338.
11. Angelini DJ, Hyun SW, Grigoryev DN, Garg P, Gong P, et al. (2006) TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. Am J Physiol Lung Cell Mol Physiol 291: L1232-1245.
12. Hudry-Clergeon H, Stengel D, Ninio E, Vilgrain I, (2005) Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase. Faseb J 19: 512-520.
13. Esser S, Lampugnani MG, Corada M, Dejana E, Risau W, (1998) Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 111 (Pt 13): 1853-1865.
14. Potter MD, Barbero S, Cheresh DA, (2005) Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 280: 31906-31912.
15. Hatanaka K, Simons M, Murakami M, (2011) Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation. Am J Physiol Heart Circ Physiol 300: H162-172.
16. Allingham MJ, van Buul JD, Burridge K, (2007) ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. J Immunol 179: 4053-4064.
17. Turowski P, Martinelli R, Crawford R, Wateridge D, Papageorgiou AP, et al. (2008) Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration. J Cell Sci 121: 29-37.
18. Grazia Lampugnani M, Zanetti A, Corada M, Takahashi T, Balconi G, et al. (2003) Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 161: 793-804.
19. Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, et al. (2002) VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. Embo J 21: 4885-4895.
20. Sui XF, Kiser TD, Hyun SW, Angelini DJ, Del Vecchio RL, et al. (2005) Receptor protein tyrosine phosphatase micro regulates the paracellular pathway in human lung microvascular endothelia. Am J Pathol 166: 1247-1258.
21. Nakamura Y, Patrushev N, Inomata H, Mehta D, Urao N, et al. (2008) Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells. Circ Res 102: 1182-1191.
22. Ukropec JA, Hollinger MK, Salva SM, Woolkalis MJ, (2000) SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J Biol Chem 275: 5983-5986.
23. Murakami M, Nguyen LT, Zhuang ZW, Moodie KL, Carmeliet P, et al. (2008) The FGF system has a key role in regulating vascular integrity. J Clin Invest 118: 3355-3366.
24. Shaw SK, Bamba PS, Perkins BN, Luscinskas FW, (2001) Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium. J Immunol 167: 2323-2330.
25. Mochizuki H, Schwartz JP, Tanaka K, Brady RO, Reiser J, (1998) High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol 72: 8873-8883.
26. Huyer G, Liu S, Kelly J, Moffat J, Payette P, et al. (1997) Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem 272: 843-851.
27. Murakami M, Horowitz A, Tang S, Ware JA, Simons M, (2002) Protein kinase C (PKC) delta regulates PKCalpha activity in a Syndecan-4-dependent manner. J Biol Chem 277: 20367-20371.
28. Chittenden TW, Claes F, Lanahan AA, Autiero M, Palac RT, et al. (2006) Selective regulation of arterial branching morphogenesis by synectin. Dev Cell 10: 783-795.
29. Ueno H, Gunn M, Dell K, Tseng A Jr, Williams L, (1992) A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor. J Biol Chem 267: 1470-1476.
30. Dejana E, Orsenigo F, Lampugnani MG, (2008) The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121: 2115-2122.
31. Baumeister U, Funke R, Ebnet K, Vorschmitt H, Koch S, et al. (2005) Association of Csk to VE-cadherin and inhibition of cell proliferation. Embo J 24: 1686-1695.
32. Gavard J, Gutkind JS, (2006) VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8: 1223-1234.
33. Wallez Y, Cand F, Cruzalegui F, Wernstedt C, Souchelnytskyi S, et al. (2007) Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene 26: 1067-1077.
34. Monaghan-Benson E, Burridge K, (2009) The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem 284: 25602-25611.
35. Adam AP, Sharenko AL, Pumiglia K, Vincent PA, (2010) Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. J Biol Chem 285: 7045-7055.
36. Murakami M, Nguyen LT, Hatanaka K, Schachterle W, Chen PY, et al. (2011) FGF-dependent regulation of VEGF receptor 2 expression in mice. J Clin Invest.
37. Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, et al. (2006) Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem 281: 15694-15700.
38. Zhao X, Peng X, Sun S, Park AY, Guan JL, (2010) Role of kinase-independent and-dependent functions of FAK in endothelial cell survival and barrier function during embryonic development. J Cell Biol 189: 955-965.
39. Nottebaum AF, Cagna G, Winderlich M, Gamp AC, Linnepe R, et al. (2008) VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. J Exp Med 205: 2929-2945.
40. Weis SM, Cheresh DA, (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437: 497-504.
41. Grinnell KL, Casserly B, Harrington EO, (2010) Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol 298: L361-370.
42. Ha CH, Bennett AM, Jin ZG, (2008) A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor. J Biol Chem 283: 7261-7270.
43. Pepper MS, Mandriota SJ, (1998) Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells. Exp Cell Res 241: 414-425.